FR3045354B1 - Procede de reduction de l'odeur corporelle provoquee par la transpiration - Google Patents

Procede de reduction de l'odeur corporelle provoquee par la transpiration Download PDF

Info

Publication number
FR3045354B1
FR3045354B1 FR1662198A FR1662198A FR3045354B1 FR 3045354 B1 FR3045354 B1 FR 3045354B1 FR 1662198 A FR1662198 A FR 1662198A FR 1662198 A FR1662198 A FR 1662198A FR 3045354 B1 FR3045354 B1 FR 3045354B1
Authority
FR
France
Prior art keywords
body odor
odor caused
breathing
reducing body
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1662198A
Other languages
English (en)
French (fr)
Other versions
FR3045354A1 (enrdf_load_stackoverflow
Inventor
Bernhard Banowski
Imme Breuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of FR3045354A1 publication Critical patent/FR3045354A1/fr
Application granted granted Critical
Publication of FR3045354B1 publication Critical patent/FR3045354B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
FR1662198A 2015-12-18 2016-12-09 Procede de reduction de l'odeur corporelle provoquee par la transpiration Expired - Fee Related FR3045354B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102015225971.4 2015-12-18
DE102015225971.4A DE102015225971A1 (de) 2015-12-18 2015-12-18 Verfahren zur Reduzierung des durch die Transpiration ausgelösten Körpergeruchs unter Verwendung von speziellen Proteinhydrolysaten

Publications (2)

Publication Number Publication Date
FR3045354A1 FR3045354A1 (enrdf_load_stackoverflow) 2017-06-23
FR3045354B1 true FR3045354B1 (fr) 2020-01-10

Family

ID=58284500

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1662198A Expired - Fee Related FR3045354B1 (fr) 2015-12-18 2016-12-09 Procede de reduction de l'odeur corporelle provoquee par la transpiration

Country Status (3)

Country Link
DE (1) DE102015225971A1 (enrdf_load_stackoverflow)
FR (1) FR3045354B1 (enrdf_load_stackoverflow)
GB (1) GB2551597B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022178598A1 (en) * 2021-02-26 2022-09-01 L'oreal Stick cosmetic compositions, use of the stick cosmetic composition and process for manufacturing the stick cosmetic composition

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
ES2261446T3 (es) * 2000-07-26 2006-11-16 Cognis France, S.A.S. Utilizacion de una composicion que inhibe el crecimiento del pelo.
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
DE10333245C5 (de) 2003-07-21 2015-02-19 Henkel Ag & Co. Kgaa Präbiotisch wirksame Pflanzenextrakte
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004032734A1 (de) * 2004-03-18 2005-10-06 Henkel Kgaa Präbiotisch wirksame Substanzen für Deodorantien
DE102006004957A1 (de) 2006-02-01 2007-08-02 Henkel Kgaa Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion/Emulsion
DE102014213225A1 (de) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit speziellen Proteinen aus Hülsenfrüchten der Gattung Glycine, welche keine Halogenide und/oder Hydroxyhalogenide von Aluminium und/oder Zirconium enthalten
DE102014213228A1 (de) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit speziellen Proteinen aus Süßgräsern der Gattung Triticum und/oder Oryza und/oder Avena, welche keine Halogenide und/oder Hydroxyhalogenide von Aluminium und/oder Zirconium enthalten
DE102014213226A1 (de) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit speziellen Proteinen aus Hautanhangsgebilden von Säugetieren, Vögeln, Fischen, Insekten oder Krustentieren, welche keine Halogenide und/oder Hydroxyhalogenide von Aluminium und/oder Zirconium enthalten
EP3166589B1 (de) * 2014-07-08 2020-04-08 Henkel AG & Co. KGaA Schweisshemmende kosmetische mittel mit speziellen proteinen aus hülsenfrüchten der gattung pisum, welche keine halogenide und/oder hydroxyhalogenide von aluminium und/oder zirconium enthalten"
DE102014216913A1 (de) * 2014-08-26 2016-03-03 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit Proteinen aus Malvengewächsen der Gattung Adansonia, welche keine Halogenide und/oder Hydroxyhalogenide von Aluminium und/oder Zirconium enthalten
DE102014221855A1 (de) * 2014-10-27 2016-04-28 Henkel Ag & Co. Kgaa Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie Proteine aus Süßgräsern der Gattung Triticum und/oder Oryza und/oder Avena, zur Reduzierung und/oder Verhinderung von Schweiß

Also Published As

Publication number Publication date
FR3045354A1 (enrdf_load_stackoverflow) 2017-06-23
GB201621426D0 (en) 2017-02-01
GB2551597A (en) 2017-12-27
GB2551597B (en) 2019-11-06
DE102015225971A1 (de) 2017-06-22

Similar Documents

Publication Publication Date Title
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
JOP20200011A1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
CL2016001715A1 (es) Nuevos inhibidores de glutaminasa
CL2019001258A1 (es) Métodos para tratar el síndrome de alport usando bardoxolona metilo o análogos de la misma.
BR112017017286A2 (pt) protease de cisteína
BR112017017284A2 (pt) protease de cisteína
EA201290041A1 (ru) Лечение расстройств, связанных с макрофагами
EA201690456A1 (ru) Способы лечения и предотвращения эндотелиальной дисфункции с применением бардоксолона метила или его аналогов
PH12015502788A1 (en) Antibody formulations and methods
UA114528C2 (uk) Комбінації активних сполук, що містять карбоксамідні похідні та засіб біологічної боротьби
MX2016011529A (es) Formulacion para analogos anticolinergicos suaves.
MX2011012015A (es) Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
JOP20210050A1 (ar) معدلات تعبير pnpla3
IN2014DN07226A (enrdf_load_stackoverflow)
MX386488B (es) Formulacion para analogos anticolinergicos blandos.
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
MX379984B (es) Reducción de la sensación de picazón en la piel.
MX380968B (es) Angiotensina ii sola o en combinacion para usarse en el tratamiento de hipotension.
MX385447B (es) Agente antihipertensivo
EP3403656A4 (en) COMPOSITION FOR PREVENTING, HEALING OR TREATING THE FEMALE CLIMATE SYNDROME WITH LOGANINE OR DERIVATIVES THEREOF AS AN ACTIVE SUBSTANCE
FR3045354B1 (fr) Procede de reduction de l'odeur corporelle provoquee par la transpiration
WO2013138338A3 (en) Methods for treating tissue damage associated with ischemia with apoliporotein d
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
JOP20210009A1 (ar) طرق لعلاج HFpEF باستعمال داباجليفلوزين وتركيبات تشمله
BR112017014552A2 (pt) ?análogo de calcitonina, e, método para produzir uma diminuição nos triglicerídeos no fígado/redução de acúmulo de gordura no fígado?

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20230808